European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Congress to you

Coverage of Acute Cardiac Care 2012

This section brings you congress news, coverage of key sessions, photos, on-site video interviews, press releases and slide resources before, during and after the congress.ACC 2012 Congress News articlesACC 2012 Congress Press releasesACC 2012 Congress PhotosACC 2012 Congress Slidesacc2012 congress content

Whether you're attending or not, make sure to bookmark and check back here for all the content from Istanbul.Congress news articlesPress Releasesphotos of the congress

 Congress News

 ‭(Hidden)‬ photos bookmark


 Photos from Acute Cardiac Care congress in Istanbul

 Slides from Acute Cardiac Care 2012


DateTitlePresenterAccess
21 Oct 2012New versus old oral antiplatelet agents: which drug and how long?U Zeymer (Ludwigshafen, Germany)public
21 Oct 2012Practical considerations - Dose and timing of ASA and P2Y12 inhibitors: is genetic or in vitro testing clinically useful?R F Storey (Sheffield, United Kingdom)public
21 Oct 2012Is there still a role for IV antiplatelet agents (GP IIb/IIIa inhibitors, cangrelor)?F Schiele (Besancon, France)public
21 Oct 2012Specific situations: patients.M Lettino (Milano, Italy)public
22 Oct 2012Patients with general comorbidities.A Budaj (Warsaw, Poland)public
22 Oct 2012Patients with acute heart failure.ICC van der Horst (Groningen, Netherlands)public
22 Oct 2012Patients with renal failure.F Schiele (Besancon, France)public
22 Oct 2012Patients with geriatric syndromes.H Bueno (Madrid, Spain)public
22 Oct 2012The fate of patients triaged in the field.P M Clemmensen (Copenhagen, Denmark)public
22 Oct 2012Network models for reperfusion in STEMI patients and emergency organisation.K Huber (Vienna, Austria)public
22 Oct 2012Pre-hospital anti thrombotic treatment before mechanical reperfusion: new perspectives.L De Luca (Roma, Italy)public
21 Oct 2012The challenge of recognising cardiogenic shock.C Hassager (Copenhagen, Denmark)public
21 Oct 2012To fill or not to fill - Balancing input and output.V-P Harjola (Helsinki, Finland)public
21 Oct 2012Inotropes - Still a role?J T Parissis (Athens, Greece)public
21 Oct 2012Managing futility.S Price (London, United Kingdom)public
22 Oct 2012Is intubation the "gold standard" in out of hospital resuscitation?B W Boettiger (Koln, Germany)public
22 Oct 2012Cooling during and after cardiac arrest - Where is the evidence taking us?J Bro-Jeppesen (Copenhagen, Denmark)public
22 Oct 2012The post cardiac arrest syndrome - Emerging concepts.N I Nikolaou (Athens, Greece)public
21 Oct 2012Pathophysiology and outcome of incessant VT, electrical storm and acute cardiac failure.F Braunschweig (Stockholm, Sweden)public
21 Oct 2012Pharmacological treatment optionsK Adalet (Istanbul, Turkey)public
21 Oct 2012Catheter ablation of incessant VT and electrical storm.J Kautzner (Prague, Czech Republic)public
21 Oct 2012Novel approaches to treat acute cardiac failure.E Gronda (Sesto S. Giovanni, Italy)public
22 Oct 2012Predictors and outcomes of bleedings.D C L Gulba (Oberhausen, Germany)public
22 Oct 2012Therapeutic measures in patients with bleedings.A Budaj (Warsaw, Poland)public
21 Oct 2012The principles and pitfalls of mechanical circulatory support.P Vranckx (Hasselt, Belgium)public
21 Oct 2012Surgical mechanical circulatory support.P M Petrou (Nicosia, Cyprus)public
21 Oct 2012Transcatheter circulatory support.C J M Vrints (Edegem, Belgium)public
21 Oct 2012When to refer for mechanical circulatory support, the INTERMACS registry.S Price (London, United Kingdom)public
20 Oct 2012The choice of antithrombotic therapy.K Huber (Vienna, Austria)public
20 Oct 2012The choice of antiplatelet therapy.R F Storey (Sheffield, United Kingdom)public
20 Oct 2012Who needs intervention?M M Degertekin (Istanbul, Turkey)public
20 Oct 2012Beta blockers and ACE inhibitors - For all?D Zahger (Beer Sheva, Israel)public
20 Oct 2012Atrial fibrillation and death after STEMI: risk marker or casual mediator?M M Gulizia (Catania, Italy)public
20 Oct 2012Rate control versus rhythm control in NSTEMI.G Kudaiberdieva (Adana, Turkey)public
20 Oct 2012Atrial fibrillation in acute heart failure.A S Manolis (Glyfada-Athens, Greece)public